Role of CYP2C8 and CYP2J2 genotype in renal-induced toxicity of calcineurin inhibitors

被引：0
|
作者：
Smith, Helen E.
Thummel, Kenneth E.
Fallon, Michael J.
Jones, J. P.
Totah, Rheem A.
Farin, Fred M.
Janssen, Patricia
Hebert, Mary F.
机构：
[1] Univ Washington, Dept Pharmaceut, Seattle, WA 98195 USA
[2] Univ Washington, Environm Hlth, Seattle, WA 98195 USA
[3] Univ Washington, Dept Pharm, Seattle, WA 98195 USA
来源：
DRUG METABOLISM REVIEWS | 2006年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
321
引用
收藏
页码：207 / 208
页数：2
相关论文
共 50 条
  • [1] Inhibitory Effects of Danshen components on CYP2C8 and CYP2J2
    Xu, Mei-juan
    Jiang, Li-feng
    Wu, Ting
    Chu, Ji-hong
    Wei, Yi-dan
    Aa, Ji-ye
    Wang, Guang-ji
    Hao, Hai-ping
    Ju, Wen-zheng
    Li, Ping
    CHEMICO-BIOLOGICAL INTERACTIONS, 2018, 289 : 15 - 22
  • [2] Detection of human CYP2C8, CYP2C9, and CYP2J2 in cardiovascular tissues
    DeLozier, Tracy C.
    Kissling, Grace E.
    Coulter, Sherry J.
    Dai, Diana
    Foley, Julie F.
    Bradbury, J. Alyce
    Murphy, Elizabeth
    Steenbergen, Charles
    Zeldin, Darryl C.
    Goldstein, Joyce A.
    DRUG METABOLISM AND DISPOSITION, 2007, 35 (04) : 682 - 688
  • [3] CYP2C8 and CYP2J2 gene variations increase the risk of hypertensive intracerebral hemorrhage
    Li, Yue
    You, Cuiping
    Liu, Zhenchuan
    He, Feng
    Zhao, Fuchun
    Song, Xiaojie
    Xie, Zhongxiang
    Wei, Shuai
    Yang, Yongfang
    Wei, Hongyan
    Che, Fengyuan
    Yu, Jixu
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2023, 32 (03):
  • [4] Association of CYP2C8, CYP2C9 and CYP2J2 gene polymorphisms with myocardial infarction in South Indian population
    Annan Sudarsan Arun Kumar
    Srinivasamurthy Suresh Kumar
    Gurusamy Umamaheswaran
    Ramasamy Kesavan
    Jayaraman Balachandar
    Chandrasekaran Adithan
    Pharmacological Reports, 2015, 67 : 97 - 101
  • [5] Association of CYP2C8, CYP2C9 and CYP2J2 gene polymorphisms with myocardial infarction in South Indian population
    Kumar, Annan Sudarsan Arun
    Kumar, Srinivasamurthy Suresh
    Umamaheswaran, Gurusamy
    Kesavan, Ramasamy
    Balachandar, Jayaraman
    Adithan, Chandrasekaran
    PHARMACOLOGICAL REPORTS, 2015, 67 (01) : 97 - 101
  • [6] Pioglitazone is metabolised by CYP2C8 and CYP3A4 in vitro:: Potential for interactions with CYP2C8 inhibitors
    Jaakkola, Tiina
    Laitila, Jouko
    Neuvonen, Pertti J.
    Backman, Janne T.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2006, 99 (01) : 44 - 51
  • [7] CYP2J2 and CYP2C8 polymorphisms and coronary heart disease risk:: the Atherosclerosis Risk in Communities (ARIC) study
    Lee, Craig R.
    North, Kari E.
    Bray, Molly S.
    Couper, David J.
    Heiss, Gerardo
    Zeldin, Darryl C.
    PHARMACOGENETICS AND GENOMICS, 2007, 17 (05): : 349 - 358
  • [8] Genetic polymorphism of CYP2C8 in three Malaysian ethnics:: CYP2C8*2 and CYP2C8*3 are found in Malaysian Indians
    Muthiah, YD
    Lee, WL
    Teh, LK
    Ong, CE
    Ismail, R
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2005, 30 (05) : 487 - 490
  • [9] Endothelial CYP2J2 and CYP2C8 Overexpression and Soluble Epoxide Hydrolase Deletion Attenuate Acute Inflammatory Responses in Mice
    Deng, Yangmei
    Theken, Katherine N.
    Edin, Matthew L.
    Kannon, M. Alison
    Schuck, Robert N.
    DeGraff, Laura M.
    Bradbury, J. Alyce
    Graves, Joan
    Zeldin, Darryl C.
    Lee, Craig R.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2009, 29 (07) : E63 - E63
  • [10] Amiodarone N-deethylation by CYP2C8 and its variants, CYP2C8*3 and CYP2C8 P404A
    Soyama, A
    Hanioka, N
    Saito, Y
    Murayama, N
    Ando, M
    Ozawa, S
    Sawada, J
    PHARMACOLOGY & TOXICOLOGY, 2002, 91 (04): : 174 - 178
12345